Protease Inhibitors: all 1,856 studies that test it

Page 19 of 19. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.

• A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV TreatmentCompletedNCT00002216Not applicable
• Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected PatientsCompletedNCT00002211Not applicable
• A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TCCompletedNCT00002208Phase 3
• An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment RegimenCompletedNCT00002205Not applicable
• A Comparison of 141W94 and Indinavir in HIV-Infected PatientsCompletedNCT00002202Phase 3
• A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected PatientsCompletedNCT00002201Not applicable
• Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease InhibitorsCompletedNCT00002193Phase 3
• A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected PatientsCompletedNCT00002190Phase 2
• A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3CompletedNCT00002185Phase 2
• The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of InfectionCompletedNCT00002179Phase 4
• A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive PatientsCompletedNCT00002178Phase 3
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV InfectionCompletedNCT00002177Not applicable
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV InfectionCompletedNCT00002176Not applicable
• A Study of Viracept in HIV-Positive WomenCompletedNCT00002171Phase 2
• A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)CompletedNCT00002170Phase 2
• A Study of Viracept in AIDS Patients With Cytomegalovirus RetinitisCompletedNCT00002169Phase 2
• Viracept Expanded Access ProgramCompletedNCT00002165Not applicable
• Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed InfantsCompletedNCT00002164Phase 1
• A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral DrugsCompletedNCT00002162Phase 2
• A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.CompletedNCT00002111Phase 1
• Once-Daily Drug Regimen for HIV-Infected PatientsCompletedNCT00001968Phase 1
• Continued Antiretroviral Therapy With Abacavir, Amprenavir and EfavirenzCompletedNCT00001758Phase 2
• A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and StavudineCompletedNCT00001688Phase 2
• A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerCompletedNCT00001683Phase 1
• A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV InfectionCompletedNCT00001443Phase 1
• Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or SaquinavirCompletedNCT00001133Phase 1
• A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken AmprenavirCompletedNCT00001095Phase 2
• A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected PatientsWithdrawnNCT00001094Phase 2
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00001087Phase 2
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected PatientsCompletedNCT00001086Phase 2
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected PatientsCompletedNCT00001084Phase 2
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedNCT00001083Phase 2
• The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected PatientsCompletedNCT00001075Not applicable
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and ChildrenCompletedNCT00000952Phase 1
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000944Phase 1
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIVCompletedNCT00000940Phase 2
• Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their NewbornsCompletedNCT00000920Phase 1
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive ChildrenCompletedNCT00000913Phase 2
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000912Phase 2
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment RegimenCompletedNCT00000903Phase 3
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenCompletedNCT00000901Phase 1
• The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and SaquinavirCompletedNCT00000898Not applicable
• Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive ChildrenCompletedNCT00000893Phase 1
• A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNCT00000892Not applicable
• Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their BabiesCompletedNCT00000888Phase 1
• A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000887Phase 1
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320CompletedNCT00000885Phase 2
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedNCT00000882Phase 2
• Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedNCT00000877Phase 1
• The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected PatientsCompletedNCT00000861Not applicable
• A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3CompletedNCT00000859Not applicable
• The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearCompletedNCT00000848Phase 2
• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More MonthsCompletedNCT00000841Phase 3
• A Phase I Randomized Dose/Formulation Comparison Study of SC-52151CompletedNCT00000806Phase 1
• A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)WithdrawnNCT00000804Not applicable
• A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's SarcomaCompletedNCT00000763Phase 1

← Protease Inhibitors overview